Featured Posts
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Newsletter
Online Privacy, Food Safety and Unemployment Benefits
The Senate Commerce Committee prepares for a hearing on consumer online privacy. Environmental groups sue to compel the Food and Drug Administration to ban the…
Newsletter
Cap and Trade, Financial Regulation and Toyotas and the Truth
Sen. John Kerry (D-MA) mentions plans to pass a cap-and-trade bill in a post-election “lame duck” session if necessary. President Obama signs the Dodd-Frank financial…
Op-Eds
Too safe for our own good?
Myths about the risks of various products and activities can themselves be harmful to your health. They include the belief that greater regulation is synonymous…
Citation
Does the FTC Really Protect Consumers?
Op-Eds
What is Government’s Role in Fighting Obesity (Letter to the Editor)
Newsletter
Climategate, Wine Regulations and the Jones Act
A recent report appears to clear scientists involved in the “Climategate” scandal of most wrongdoing. Congress sidelines a bill that would have created new restrictions…